Life-threatening hemolytic-uremic syndrome treated with rituximab in an allogeneic bone marrow transplant recipient

被引:24
作者
Ostronoff, M. [1 ]
Ostronoff, F. [1 ]
Calixto, R. [1 ]
Florencio, R. [1 ]
Florencio, M. [1 ]
Domingues, M. C. [1 ]
Maior, A. P. Souto [1 ]
Sucupira, A. [1 ]
Tagliari, C. [1 ]
机构
[1] Real Hosp Portugues, Hematol & Bone Marrow Transplantat Unit, Recife, PE, Brazil
关键词
D O I
10.1038/sj.bmt.1705657
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:649 / 651
页数:3
相关论文
共 16 条
[1]  
BRANDALISE S, 1993, LEUKEMIA, V7, pS142
[2]   Immunotherapy for thrombotic thrombocytopenic purpura [J].
Cataland, SR ;
Wu, HFM .
CURRENT OPINION IN HEMATOLOGY, 2005, 12 (05) :359-363
[3]   Efficiency of curative and prophylactic treatment with rituximab in ADAMTS 13-deficient thrombotic thrombocytopenic purpura:: a study of 11 cases [J].
Fakhouri, F ;
Vernant, JP ;
Veyradier, A ;
Wolf, M ;
Kaplanski, G ;
Binaut, R ;
Rieger, M ;
Scheiflinger, F ;
Poullin, P ;
Deroure, B ;
Delarue, R ;
Lesavre, P ;
Vanhille, P ;
Hermine, O ;
Remuzzi, G ;
Grünfeld, JP .
BLOOD, 2005, 106 (06) :1932-1937
[4]   The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation [J].
Fuge, R ;
Bird, J M ;
Fraser, A ;
Hart, D ;
Hunt, L ;
Cornish, JM ;
Goulden, N ;
Oakhill, A ;
Pamphilon, DH ;
Steward, CG ;
Marks, DI .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (01) :58-64
[5]   Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome [J].
Furlan, M ;
Robles, R ;
Galbusera, M ;
Remuzzi, G ;
Kyrle, PA ;
Brenner, B ;
Krause, M ;
Scharrer, I ;
Aumann, V ;
Mittler, U ;
Solenthaler, M ;
Lämmle, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (22) :1578-1584
[6]   Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma [J].
George, JN ;
Li, XN ;
McMinn, JR ;
Terrell, DR ;
Vesely, SK ;
Selby, GB .
TRANSFUSION, 2004, 44 (02) :294-304
[7]   Blood and marrow transplant clinical trials network toxicity committee consensus summary: Thrombotic microangiopathy after hematopoietic stem cell transplantation [J].
Ho, VT ;
Cutler, C ;
Carter, S ;
Martin, P ;
Adams, R ;
Horowitz, M ;
Ferrara, J ;
Soiffer, R ;
Giralt, S .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (08) :571-575
[8]   Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation [J].
Iacopino, P ;
Pucci, G ;
Arcese, W ;
Bosi, A ;
Falda, M ;
Locatelli, F ;
Marenco, P ;
Miniero, R ;
Morabito, F ;
Rossetti, F ;
Sica, S ;
Uderzo, C ;
Bacigalupo, A .
BONE MARROW TRANSPLANTATION, 1999, 24 (01) :47-51
[9]   Coagulation abnormalities and thrombotic microangiopathy following bone marrow transplantation from HLA-matched unrelated donors in patients with hematological malignancies [J].
Natazuka, T ;
Kajimoto, K ;
Ogawa, R ;
Imoto, S ;
Koizumi, T ;
Nishimura, R ;
Nakagawa, T .
BONE MARROW TRANSPLANTATION, 1998, 21 (08) :815-819
[10]  
PETTITT AR, 1994, BONE MARROW TRANSPL, V14, P495